582 Results (Page 3 of 24)
US Markets Research Reports
US Anti-Depressants Drugs Market Analysis
The US Anti-depressant drugs market size was valued at $6.9 billion in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3.9% from 2022 to 2030 and will reach $9.37 billion in 2030. The market is segmented by drug class, indication, route of administration, end-user, and distribution channel. The US Anti-depressant drug market will grow because of the development of novel antidepressant drugs and the expansion of the product portfolio of pharmaceutical companies. The key market players are Eli Lilly and Company (USA), Pfizer Inc. (USA), Bristol-Myers Squibb (USA), and others.
US Pharmaceutical Market Analysis
The US Pharmaceutical Market is projected to grow from $567 Bn in 2022 to $903 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US pharmaceutical market is characterized by a high degree of competition and consolidation, with a few large companies dominating the industry. Some of the top pharmaceutical companies in the US include Pfizer, Johnson & Johnson, Merck & Co., and AbbVie.
US Cardiac Arrhythmia Therapeutics Market Analysis
US Cardiac Arrhythmia Therapeutics Market valued at $3.024 Bn in 2022, projected to reach $4.075 Bn by 2030 with a 3.8% CAGR. The key drivers of this industry include the rising prevalence of CVDs, technological advancements, and supportive government initiatives. The industry is primarily dominated by players such as Abbott, Medtronic, Bayer, Pfizer, Johnson & Johnson, and Bristol Myers Squibb among others.
US Cardiac Resynchronization Therapy Market
US Cardiac Resynchronization Therapy Market valued at $2,016 Mn in 2022, projected to reach $2,554 Mn by 2030 with a 3% CAGR. The increasing worldwide incidence of heart failure, propelled by aging demographics and cardiovascular diseases linked to lifestyle, emerges as a significant factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, prominent players in this market encompass Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
US Castrate Resistant Prostate Cancer Therapeutics Market Analysis
US Castrate Resistant Prostate Cancer Therapeutics Market valued at $4.28 Bn in 2022, projected to reach $6.38 Bn by 2030 with a 5.10% CAGR. The key drivers include streamlined regulatory procedures, balancing patient access and innovation, constant observation of dynamic market dynamics, and efforts to increase public awareness and facilitate timely diagnosis. The US Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Bayer, Roche, Astellas Pharma, Sanofi, Novartis, AstraZeneca, Bausch, Amgen, etc, among various others.
US Alzheimer’s Therapeutics Market Analysis
US alzheimer’s therapeutics market valued at $2016 Mn in 2022, projected to reach $3490 Mn by 2030 with a 7.1% CAGR. The factors boosting the market's growth are the rising prevalence of Alzheimer's disease and the approval of therapies that can change the course of the illness. Leading pharmaceutical companies that are currently working in the market are Eisai, Biogen, Roche, Eli Lilly, Merck & Co., Genentech, AbbVie, Johnson & Johnson, Novartis and Pfizer.
US Infectious Disease Drugs Market Analysis
US Infectious Disease Drugs Market valued at $49.87 Bn in 2023, projected to reach $58.36 Bn by 2030 with a 2.27% CAGR. The market is expanding due to the prevalence of infectious diseases, improvements in drug development, and an aging population. The market is dominated by key players like AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, Pfizer Inc., and Lupin Pharmaceuticals.
US Atopic Dermatitis Therapeutics Market Analysis
The US Atopic Dermatitis Therapeutics Market was valued at US $5.166 Bn in 2022, and is predicted to grow at (CAGR) of 6.8% from 2023 to 2030, to US $8.744 Bn by 2030. The key drivers of this industry include the rising prevalence of Atopic Dermatitis (AD), innovative drugs in the pipeline and evolving healthcare landscape. The industry is primarily dominated by players such as Sanofi, AbbVie, Pfizer, Regeneron, Eli Lilly, Astellas among others.
US Atherosclerosis Therapeutics Market Analysis
US Atherosclerosis Therapeutics Market was valued at $1176 Mn in 2022 and is estimated to reach $1573 Mn in 2030, exhibiting a CAGR of 3.7% during the forecast period. The market for atherosclerosis therapeutics is expected to grow as a result of the increased incidence of sedentary behaviour, poor diets, and the aging of the world's population, which are all contributing factors to the prevalence of cardiovascular diseases. Top leading pharmaceutical companies currently operating in the market are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Johnson & Johnson, Eli Lilly, AbbVie, Roche and Amgen.
US Asthma and COPD Therapeutics Market Analysis
The US Asthma and COPD Therapeutics Market was valued at US $14.03 Bn in 2022, and is predicted to grow at (CAGR) of 3.20% from 2023 to 2030, to US $18.05 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of COPD and asthma, advanced treatments, rising healthcare spending, and others. The industry is primarily dominated by players such as AstraZeneca, Novartis, Teva US, GSK, Novartis Pfizer, and Boehringer Ingelheim, among others
US HIV Drugs Market Analysis
US HIV Drugs Market is at around $13.31 Bn in 2023 and is projected to reach $14.88 Bn in 2030, exhibiting a CAGR of 1.6% during the forecast period. The market is driven by rising HIV prevalence, improvements in drug development, and increased testing and awareness campaigns. The market is dominated by key players like Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffman-La Roche Ltd., Cipla, Teva Pharmaceutical Industries Ltd., and Johnson & Johnson.
US Antifungal Drugs Market Analysis
US Antifungal Drugs Market is at around $6.64 Bn in 2023 and is projected to reach $7.52 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. The market is being driven by rising rates of fungal infections, improvements in drug development, and increase in antifungal resistance. The market is dominated by key players like Pfizer Inc., Merck & Co., Inc., Astellas Pharma Inc., Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi, and Enzon Pharmaceuticals, Inc.
US Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis
US Methicillin-resistant Staphylococcus Aureus (MRSA) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in governmental and private financing for research and development of novel anti-MRSA medications as well as their improved screening are the main drivers of the growth of the market for treating methicillin-resistant staphylococcus aureus (MRSA). Some of the major key players in this market are Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Melinta Therapeutics, Inc., etc.
US Microspheres Market Analysis
US microspheres market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Medical science and technology improvements as well as rising usage in the medical business are the main drivers of the market under study. The key players in this market are Nouryon Chemicals Holding B.V., Trelleborg AB, Chase Corporation, Mo SCI Corporation, 3M Co., and Kureha Corporation.
US Migraine Drugs Market Analysis
US migraine drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. High alcohol consumption, rising healthcare costs, rising job stress, and rising medicine demand are all expected to drive market expansion. In the years ahead, it is anticipated that there will be a rise in public knowledge of migraines and available treatments which will further act as a driver for Migraine Drugs Market. The major key players in this market are Amgen, Abbott Laboratories, Allergan, Eli Lilly, Pfizer, Inc., AstraZeneca, Johnson and Johnson Services, Inc., and GlaxoSmithKline.
US Multiple Myeloma Drugs Market Analysis
US multiple myeloma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of the illness, new technologies, and improved healthcare systems are a few of the elements boosting the revenue of the worldwide multiple myeloma market. The major key players in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Genentech Inc. (F. Hoffmann-La Roche Ltd), Novartis AG, etc.
US Nanomedicine Market Analysis
US nanomedicine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Shortly, significant advancements and the recent commercialization of goods like mRNA- and liposome-based vaccines are anticipated to fuel the rise of nanomedicines. The major key players in this market are Abbott Laboratories, CombiMatrix Corporation, Celgene Corporation, etc.
US Nanotechnology Drugs Delivery Market Analysis
US nanotechnology drugs delivery market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for nanotechnology medication delivery is heavily influenced by factors like expanding public awareness of nanotechnology, an increase in the prevalence of chronic illnesses, technological improvement, and rising government investment in nanotechnology in various emerging nations. The major key players in this market are AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG.
US NSCLC Drugs Market Analysis
US NSCLC Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 � 2030. During the projection period, the global non-small cell lung cancer market will grow due to the rise in cancer cases worldwide. Oral medications are predicted to accelerate market expansion. Given that the majority of medications are accessible in capsule and tablet form and that this is a very practical mode of administration, the category is anticipated to accelerate the global market.The global NSCLC Drugs market�s major key players are AstraZeneca PLC, Roche Holding AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, Novartis AG, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Johnson & Johnson.
US Oncology Biosimilars Market Analysis
US oncology biosimilars market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased incidence of cancer is driving the global market. Furthermore, the market is expanding as more people become aware of the existence of oncology biosimilars. Additionally, the advancements in biosimilar manufacturing technologies and procedures have expanded production capacities. The major key players in this market are Sandoz International GmbH, Celltrion Inc., Pfizer Inc., Amgen Inc., Samsung Bioepis, etc.
US Oncology/Cancer Drugs Market Analysis
US oncology/cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally rising cancer rates, rising demand for cutting-edge treatments like targeted medication therapies, an increase in the geriatric population, and pervasive lifestyle behaviors like smoking, drinking, and not exercising will all have a positive impact on the market during the projected period. The major key players in this market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, etc.
US Ophthalmic Drugs Market Analysis
US ophthalmic drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 � 2030. The key factors driving the growth of the global ophthalmic drugs market are the rise in the elderly population, the prevalence of eye diseases like glaucoma, cataracts, and macular degeneration, the surge in ophthalmic drug demand, and the increase in investment in R&D activities by different healthcare companies. The major key players in this market are Pfizer Inc., Alcon, Novartis AG, Bausch Health Companies Inc., Merck & Co., Inc., Regeneron Pharmaceuticals Inc., Allergan (AbbVie Inc.), Bayer AG, Genentech, Inc. (F. Hoffmann-La Roche Ltd), Nicox, Coherus Biosciences, Inc.
US Opioid Drugs Market Analysis
US opioid drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 � 2030. The opioid industry is anticipated to rise as a result of expanding painkiller care facilities, altered prescription laws, and intense generic manufacturers' attention on Abuse-Deterrent Formulation (ADF). The major players in this market are Eva Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, and Purdue Pharmaceuticals L.P.
US Opioid Pain Management Market Analysis
US opioid pain management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Some of the main factors influencing the market's growth include an increase in the use of these painkillers and an increase in the proportion of the elderly population that is particularly susceptible to orthopaedic pain. Additionally, there has been a significant increase in the number of people worldwide who experience chronic pain. The major key players in this market are Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., etc.
US Opioid Use Disorder Market Analysis
US opioid use disorder market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for opioid use disorders is anticipated to expand in the upcoming years as a result of factors such as an expansion of the patient base and the anticipated introduction of cutting-edge therapies by top firms like Braeburn Pharmaceuticals, BioXcel Therapeutics, MediciNova, AstraZeneca, and others. Some of the major key players in this market are AstraZeneca Plc., BioDelivery Sciences International Inc., Braeburn, Cerebral, Hikma Pharmaceuticals Plc., etc.